Effect of Noradrenergic Drugs Explored in Alzheimer Disease

FRIDAY, July 29, 2022 (HealthDay News) -- Noradrenergic drugs seem to have a positive effect for general cognition and apathy in Alzheimer disease, according to a review published online July 5 in the Journal of Neurology, Neurosurgery & Psychiatry.
Michael C.B. David, M.B.B.S., from Imperial College London, and colleagues conducted a systematic review and meta-analysis to examine the efficacy of drugs with principally noradrenergic action in improving cognitive and neuropsychiatric symptoms in Alzheimer disease.
Nineteen randomized controlled trials with 1,811 patients were included; of these trials, six, seven, and six were judged as good, fair, and poor quality, respectively. The researchers found that noradrenergic drugs had a significant, small positive effect on global cognition in a meta-analysis of 10 trials (1,300 patients), measured using the Mini-Mental State Examination or Alzheimer’s Disease Assessment Scale-Cognitive subscale. There was no significant effect on measures of attention. A large positive effect of noradrenergic drugs was detected in the meta-analysis of eight trials (425 patients) examining apathy. After removal of outliers to account for heterogeneity across studies, this positive effect was still present.
"Based on this meta-analysis, and recognition of the importance of locus coeruleus-noradrenergic system in multiple neurodegenerative diseases, there is a case for further clinical trials of noradrenergic agents in Alzheimer's disease and other neurodegenerative conditions," the authors write.
Related Posts
Decision Support System Cuts Pneumonia Deaths in Community Hospitals
WEDNESDAY, March 23, 2022 (HealthDay News) -- A real-time electronic decision...
COVID-19-Related Stress During Pregnancy Tied to Poor Postpartum Outcomes
THURSDAY, March 16, 2023 (HealthDay News) -- Antenatal COVID-19-related stress...
Major Trial of Monkeypox Treatment TPOXX to Launch in Africa
MONDAY, Oct. 17, 2022 (HealthDay News) -- The ability of TPOXX to treat people...
Sleep Disturbance Highly Prevalent in Psoriasis Patients
TUESDAY, Feb. 15, 2022 (HealthDay News) -- Sleep disturbance is highly prevalent...